Merck Reports Earnings

Merck & Co. (MRK) reported second quarter 2013 earnings of 84 cents per share, two cents above the average estimate of 82 cents. Earnings, however, declined 20% from the year-ago period.

Revenues for the quarter fell 10.6% to $11,010 million, missing consensus estimates of $11,221 million.

Including one-time items, second quarter 2013 earnings declined 48.3% to 30 cents per share.

Merck & Co. (MRK).

Pfizer Inc. (PFE) is up +19.46% year-to-date.

Both comments and pings are currently closed.

Comments are closed.


Warning: Invalid argument supplied for foreach() in /home/customer/www/dow-jones-djia.com/public_html/wp-includes/script-loader.php on line 2781